[1]李 晶,屈 勇,YAROV(哈萨克斯坦).血浆可溶性CD146与2型糖尿病患者肾功能关系及对白蛋白尿短期进展的预测价值研究[J].陕西医学杂志,2023,52(3):282-286.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.008]
　LI Jing,QU Yong,YAROV.Relationship between plasma soluble CD146 and renal function in patients with type 2 diabetes mellitus and its predictive value for short-term progression of albuminuria[J].,2023,52(3):282-286.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.008]
点击复制

血浆可溶性CD146与2型糖尿病患者肾功能关系及对白蛋白尿短期进展的预测价值研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年3期
页码:
282-286
栏目:
临床研究
出版日期:
2023-03-05

文章信息/Info

Title:
Relationship between plasma soluble CD146 and renal function in patients with type 2 diabetes mellitus and its predictive value for short-term progression of albuminuria
作者:
李 晶1; 屈 勇1; YAROV2(哈萨克斯坦)
(1.西电集团医院内分泌科,陕西 西安 710077; 2.陕西中医药大学,陕西 咸阳 712046)
Author(s):
LI Jing; QU Yong; YAROV
(Department of Endocrinology,XD Group Hospital,Xi'an 710077,China)
关键词:
2型糖尿病;  糖尿病肾病;  可溶性CD146;  肾功能;  白蛋白尿;  预测价值
Keywords:
Type 2 diabetes mellitus;  Diabetic nephropathy;  Soluble CD146;  Renal function;  Albuminuria;  Predictive value
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7377.2023.03.008
文献标志码:
A
摘要:
目的:分析血浆可溶性CD146与2型糖尿病患者肾功能的关系及对白蛋白尿短期进展的预测价值。方法:选择2型糖尿病住院患者186例为研究对象,根据24 h尿白蛋白定量分为无白蛋白尿组(<20 mg/24 h,86例)、微量白蛋白尿组(20～200 mg/24 h,68例)和大量白蛋白尿组(>200 mg/24 h,32例),比较三组一般资料及实验室指标。随访12个月后,根据白蛋白尿进展情况将患者分为白蛋白尿进展组和非进展组,比较两组患者一般资料及实验室指标。分析血浆可溶性CD146与血肌酐(Scr)、肾小球滤过率(GFR)的相关性。分析2型糖尿病患者白蛋白尿短期进展的危险因素,并使用多重模型校正相关混杂因素。评价血浆可溶性CD146对白蛋白尿短期进展的预测价值。结果:随着2型糖尿病患者尿白蛋白含量增加,无白蛋白尿组、微量白蛋白尿组及大量白蛋白尿组血浆可溶性CD146水平依次升高(均P<0.05)。与无白蛋白尿组和微量白蛋白尿组比较,大量白蛋白尿组Scr水平更高,GFR水平更低(均P<0.05)。186例患者均获得随访,其中白蛋白尿短期进展48例,归入白蛋白尿进展组,其余138例归入白蛋白尿非进展组。白蛋白尿进展组Scr及血浆可溶性CD146水平高于白蛋白尿非进展组,GFR水平低于白蛋白尿非进展组(均P<0.05)。经Pearson相关性分析,2型糖尿病患者血浆可溶性CD146水平与Scr水平呈正相关(r=0.259,P=0.013),与GFR呈负相关(r=-0.316,P=0.000)。经多因素Logistic回归分析并校正混杂因素,血浆可溶性CD146水平是2型糖尿病患者白蛋白尿短期进展的独立危险因素(P<0.05)。经受试者工作特征(ROC)曲线分析,血浆可溶性CD146水平对2型糖尿病患者白蛋白尿短期进展具有较高的预测价值,高于Scr和GFR(Z=2.642、2.239,均P<0.05)。结论:血浆可溶性CD146可以反映2型糖尿病患者肾功能,对白蛋白尿短期进展有一定的预测价值。
Abstract:
Objective:To analyze the relationship between plasma soluble CD146 and renal function in patients with type 2 diabetes mellitus and its predictive value for short-term progression of albuminuria.Methods:A total of 186 inpatients with type 2 diabetes mellitus were selected and divided into no non-albuminuria group(<20 mg/24 h,86 cases),microalbuminuria group(20 to 200 mg/24 h,68 cases)and large albuminuria group(>200 mg/24 h,32 cases)according to the 24-hour urine albumin quantitative,and general data and laboratory parameters were compared between three groups.After 12 months of follow-up,patients were divided into progressive albuminuria group and non-progressive albuminuria group based on albuminuria progression,and general data and laboratory parameters were compared between two groups.The association of plasma soluble CD146 with Scr and GFR was analyzed.Risk factors for short-term progression of albuminuria in patients with type 2 diabetes were analyzed,and multiple models were used to adjust for associated confounders.The predictive value of plasma soluble CD146 for the short-term progression of albuminuria was evaluated.Results:The plasma soluble CD146 level increased sequentially in non-albuminuria,microalbuminuria,and large albuminuria groups in patients with type 2 diabetes mellitus(all P<0.05).Compared with non-albuminuria and microalbuminuria groups,large albuminuria group had higher level of Scr and lower level of GFR(all P<0.05).A total of 186 patients were followed up,of whom 48 had short-term progression of albuminuria,which was classified as progressive albuminuria group,and 138 as non-progressive albuminuria group.The levels of Scr and plasma soluble CD146 in progressive albuminuria group were higher than those in non-progressive albuminuria group,and the level of GFR was lower than that in non-progressive albuminuria group(all P<0.05).Pearson correlation analysis showed that plasma soluble CD146 level was positively correlated with Scr level in patients with type 2 diabetes(r=0.259,P=0.013)and negatively correlated with GFR(r=-0.316,P=0.000).Multivariate Logistic regression and adjustment for confounders factors showed that plasma soluble CD146 level was an independent risk factor for the short-term progression of albuminuria in patients with type 2 diabetes mellitus(P<0.05).In ROC curve analysis,plasma soluble CD146 level had higher predictive value for short-term progression of albuminuria in type 2 diabetes mellitus than Scr and GFR(Z=2.642 and 2.239,all P<0.05).Conclusion:Plasma soluble CD146 reflects renal function in patients with type 2 diabetes mellitus and has some predictive value for the short-term progression of albuminuria.

参考文献/References:

[1] 张 静,孙 仙,张文玲,等.基于分位数回归模型的2型糖尿病住院患者生命质量影响因素分析[J].中华疾病控制杂志,2020,24(2):183-188.
[2] Coskun ZM,Ersoz M,Adas M,et al.Kruppel-like transcription factor-4 gene expression and DNA methylation status in type 2 diabetes and diabetic nephropathy patients[J].Archives of Medical Research,2019,50(3):91-97.
[3] Sasso FC,Pafundi PC,Simeon V,et al.Efficacy and durability of multifactorial intervention on mortality and MACEs:A randomized clinical trial in type-2 diabetic kidney disease[J].Cardiovascular Diabetology,2021,20(1):145.
[4] 黄思华,吴锡信.肌酐全年龄阶段新公式在慢性肾脏病患者中的临床应用研究[J].中华危重病急救医学,2018,30(9):877-881.
[5] 季学清,刘 萍,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究[J].陕西中医,2020,41(9):1208-1211.
[6] 姬荣伟,刘秋霞,田亚宁,等.卵巢癌术前新辅助化疗疗效及对组织CA-125、CD146、SP70的表达影响[J].陕西医学杂志,2018,47(12):1648-1650,1666.
[7] 姬荣伟,田刘曼,陈 敏,等.CD146、SP70在卵巢上皮性癌组织中的表达及意义[J].陕西医学杂志,2018,47(5):550-553,560.
[8] Fan Y,Yang F,Zheng L,et al.Expression of endothelial cell injury marker CD146 correlates with disease severity and predicts the renal outcomes in patients with diabetic nephropathy[J].Cell Physiol Biochem,2018,48(1):63-74.
[9] 王漪芸,费 杨,范 瑛,等.糖尿病肾病患者血浆可溶性CD146水平与动脉粥样硬化及其预后的关系[J].中华糖尿病杂志,2018,10(4):274-279.
[10] Haku S,Wakui H,Azushima K,et al.Early enhanced leucine-rich α-2-glycoprotein-1 expression in glomerular endothelial cells of type 2 diabetic nephropathy model mice[J].Biomed Research International,2018,13(7):1-9.
[11] 马 莹,陈丽萌.CD146与肾脏微血管损伤的研究进展[J].中华肾脏病杂志,2017,33(3):229-231.
[12] 陶 立,马文军,龚梦嘉,等.糖尿病肾病患者尿源性干细胞的分离鉴定及与健康人尿源性干细胞的细胞生物学比较研究[J].中国细胞生物学学报,2018,40(2):194-201.
[13] 王佩佩,窦艳娜,李阿芳,等.可溶性CD146在血液透析患者水负荷状态评估中的作用[J].中华肾脏病杂志,2019,35(12):937-940.
[14] 吴恒兰,朱富祥,陈建祥,等.高糖对人脐静脉内皮细胞表达的黏附分子CD146的影响[J].中国中西医结合肾病杂志,2019,20(5):436-438.
[15] Maeva D,Marie N,Damien A,et al.Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma[J].Theranostics,2018,8(9):2447-2458.
[16] 王婷婷,李明杰,林 宁,等.血清高尿酸水平与住院糖尿病患者白蛋白尿短期进展的关系研究[J].上海交通大学学报:医学版,2019,39(7):754-758.
[17] Abed A,Leroyer AS,Kavvadas P,et al.Endothelial-specific deletion of CD146 protects against experimental glomerulonephritis in mice[J].Hypertension,2021,77(4):1260-1272.
[18] Savarin M,Kamensek U,Znidar K,et al.Evaluation of a novel plasmid for simultaneous gene electrotransfer-mediated silencing of CD105 and CD146 in combination with irradiation[J].International Journal of Molecular Sciences,2021,22(6):3069.
[19] 贺 珊.血清可溶性CD146与胱抑素C在早期糖尿病肾病诊断中的作用[J].医药论坛杂志,2021,42(6):119-122.
[20] 陈 默.老年糖尿病肾病患者血清可溶性CD146与空腹血糖水平的关系[J].中国社区医师,2021,37(1):85-86.
[21] 王声翰,杨菊红,郑妙艳,等.可溶性CD36与2型糖尿病及其并发症的关系[J].中华全科医学,2020,18(11):131-134.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
　GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(3):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
　YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(3):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
　WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(3):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
　WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(3):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]张静雯,汪 宁,邱红霞,等.非布司他治疗早期糖尿病肾病合并高尿酸血症疗效及对患者肾功能影响研究*[J].陕西医学杂志,2020,49(2):209.
　ZHANG Jingwen,WANG Ning,QIU Hongxia,et al.Efficacy of febuxostat on early diabetic nephropathy with hyperuricemia and its effect on renal function[J].,2020,49(3):209.
[11]薛海燕,李振江,孔令强.不同分期糖尿病肾病患者25羟维生素D、低氧诱导因子-1α检测及临床意义[J].陕西医学杂志,2021,50(5):614.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.025]
　XUE Haiyan,LI Zhenjiang,KONG Lingqiang.Expression and significance of 25-hydroxyvitamin D and hypoxia-inducible factor-1α in patients with diabetic nephropathy in different stages[J].,2021,50(3):614.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.025]
[12]闫 妮,刘玲娇,余湘尤,等.中性粒细胞与淋巴细胞比值在2型糖尿病合并糖尿病肾病患者中的变化及检测价值研究[J].陕西医学杂志,2021,50(6):673.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.008]
　YAN Ni,LIU Lingjiao,YU Xiangyou,et al.Change and detection value of NLR in T2DM patients with DKD[J].,2021,50(3):673.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.008]

备注/Memo

备注/Memo:
基金项目:西安市科学技术局高端外国专家引进计划项目(G2022041016L)
更新日期/Last Update: 2023-03-06